Jess Thomas

K&L Gates Adds Four-Partner, Multi-Office Premier Renewable Energy Team

Global law firm K&L Gates LLP has added a team of four high-profile partners with substantial experience in the renewable energy sector, continuing a path of strategic growth that has included the addition of more than 120 new partners and of counsel since the start of 2020 and the opening of new offices in Nashville and Luxembourg in 2021.

BRIM Biotechnology, Inc. and Ora, Inc. Announce New Partnership to Accelerate the Development of Regenerative Peptide Therapy, BRM421 for Dry Eye Syndrome

BRIM Biotechnology, Inc. ("BRIM") a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. ("ORA") the world's leading, ophthalmic research organization, for the late-stage clinical development of lead drug candidate, BRM421, for dry eye syndrome (DES). BRIM intends to initiate Phase 3 clinical studies with Ora's support later this year.

Verano Launches Mobile Applications and Exclusive Rewards Programs for Flagship Zen Leaf and MÜV Cannabis Dispensaries

Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) ("Verano" or the "Company"), a leading multi-state cannabis company, today announced the launch of mobile applications for the Company's flagship Zen Leaf and MÜV dispensaries, unlocking an additional digital channel for shoppers to order cannabis products and access exclusive rewards across a total of 71 dispensaries in seven states.

Verano Receives Permission to File U.S. GAAP Financials on SEDAR and Withdraws MCTO Application

Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) ("Verano" or the "Company"), a leading multi-state cannabis company, today announced it has received a decision (the "Decision") from the Alberta Securities Commission ("ASC") and Ontario Securities Commission ("OSC") permitting the Company to file on the System for Electronic Document Analysis and Retrieval ("SEDAR") in Canada at www.sedar.com its 2021 annual and 2022 first quarter financial statements and related management's discussion and analysis prepared in accordance with U.S. GAAP and with respect to the annual financials, audited in accordance with United States auditing standards.

Verano to Release U.S. GAAP Fourth Quarter and Full Year 2021 Financial Results on April 27th and First Quarter 2022 Results on May 25th

Company Also Announces Submission of MCTO Application. Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) ("Verano" or the "Company"), a leading multi-state cannabis company, today announced it will release U.S. GAAP financial results for the fourth quarter and full year ended December 31, 2021, before the market opens on Wednesday, April 27, 2022, and also announced it will release first quarter results for the quarter ended on March 31, 2022, before the market opens on May 25, 2022.
Vitafoods-2021

Event Preview: Vitafoods Europe Returns in May 2022

Vitafoods Europe is back once again — at its usual May timeslot — combining an online platform and the in-person event in Geneva to reconnect and inspire the nutraceutical community in an ever-changing and increasingly health-conscious, post-COVID world.
A picture of a human brain

HMNC Brain Health and Develco Pharma Announce Promising Preliminary Results in Treatment-Resistant Depression (TRD)

HMNC Brain Health ("HMNC'' or the "Company"), a global clinical stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry, together with Develco Pharma, a company specializing in the development and manufacture of orally administered modified, prolonged & chrono release drugs today announced promising top-line results from the Phase 2 Proof-of-Concept investigator-initiated trial of its oral prolonged-release formulation of ketamine (KET01) in Treatment-Resistant Depression (TRD).
1 2 3 4
Most Popular

Recommended Stories